|
Changes in clinical outcome in baseline, three months and 12 months |
|||||
| n |
Baseline mean (SD) |
Change from baseline to 3 months* mean (95% CI) |
Change from baseline to 12 months mean (95% CI) |
Change at 12 months % |
|
|
|
|||||
| Weight (kg) |
237 |
91.7 (17.7) |
-2.38 (-2.79,-1.98) |
-2.52 (-3.19,-1.85) |
-2.7 |
| Body-mass index (kg/m2) |
237 |
33.5 (5.9) |
-0.88 (-1.03,-0.74) |
-0.93 (-1.17,-0.69) |
-2.8 |
| Waist circumference (cm) |
236 |
104.9 (13.0) |
-3.16 (-3.72,-2.60) |
-4.17 (-4.87,-3.48) |
-4.0 |
| Hip circumference (cm) |
236 |
115.7 (12.5) |
-1.56 (-2.04,-1.07) |
-2.65 (-3.26,-2.05) |
-2.3 |
| Plasma glucose (mmol/l) |
|||||
| Fasting |
237 |
5.53 (0.54) |
0.00 (-0.07,0.08) |
-0.14 (-0.20,-0.07) |
-2.5 |
| 2 Hr oral glucose challenge |
232 |
6.70 (1.69) |
- |
-0.58 (-0.79,-0.36) |
-8.6 |
| Serum lipids (mmol/l) |
|||||
| Total cholesterol |
237 |
5.67 (1.15) |
-0.21 (-0.32,-0.09) |
-0.29 (-0.40,-0.18) |
-5.1 |
| Low-density lipoprotein cholesterol |
229 |
3.44 (0.99) |
-0.16 (-0.25,-0.07) |
-0.25 (-0.34,-0.16) |
-7.3 |
| High-density lipoprotein cholesterol |
237 |
1.34 (0.37) |
0.01 (-0.02,0.03) |
0.06 (0.03,0.09) |
+4.4 |
| Triglycerides |
237 |
1.90 (1.00) |
-0.10 (-0.20,0.01) |
-0.15 (-0.24,-0.05) |
-7.6 |
| Blood pressure (mmHg) |
|||||
| Systolic |
236 |
132.1 (17.1) |
-1.67 (-3.3,-0.04) |
-1.01 (-2.60,0.58) |
-0.8 |
| Diastolic |
236 |
81.0 (9.9) |
-0.99 (-2.18,0.20) |
-2.14 (-3.33,-0.94) |
-2.6 |
|
* At the 3 month clinical test, n value varied between 216 and 221. | |||||
Laatikainen et al. BMC Public Health 2007 7:249 doi:10.1186/1471-2458-7-249 |
|||||